glucose, (beta-d)-isomer has been researched along with Ebola Hemorrhagic Fever in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, K; Fisher, C; Hagen, KR; Jahrling, PB; Johnson, RF; Keshwara, R; Kurup, D; Papaneri, A; Perry, DL; Schnell, MJ; Ter Meulen, J; Wang, JT; Wirblich, C | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Ebola Hemorrhagic Fever
Article | Year |
---|---|
An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Ebola Vaccines; Ebolavirus; Emulsions; Female; Glucosides; Hemorrhagic Fever, Ebola; Lipid A; Macaca fascicularis; Macaca mulatta; Male; Rabies; Rabies Vaccines; Rabies virus; Toll-Like Receptor 4; Vaccines, Inactivated; Vaccines, Synthetic | 2016 |